The therapeutic value of Erythropoietin in preventing the negative effects of methotrexate on the Lung

Pharmacology, Toxicology and Pharmaceutical Science

1. Methotrexate 100%
2. Erythropoietin 100%
3. Malignant Neoplasm 18%
4. Diseases 9%
5. Fibrosis 9%
6. Lung Disease 9%
7. Lung Fibrosis 6%
8. Chemotherapy 6%
9. Dyspnea 6%
10. Lung Toxicity 6%
11. Antioxidant 6%
12. Salicylate Sodium 6%
13. Interstitial Lung Disease 6%
14. Inflammation 6%
15. Recombinant Erythropoietin 6%